2012欧洲心力衰竭指南引发的思考
卢永昕
摘要(Abstract)：
<正>2012年心力衰竭(心衰)领域最重要的事件是欧洲心脏病学会(European Society of Cardiology,ESC)发表了急性和慢性心衰诊断和治疗的指南[1]。主要更新的内容包括:盐皮质激素受体拮抗剂扩展到纽约心脏病协会(NYHA)心功能分级Ⅱ级射血分数降低的心衰(HfrEF)患者;窦房结If电流拮抗剂依伐布雷定可用于β受体阻滞剂未能使收缩性心衰患者心率达标时;心脏再同步化治
关键词(KeyWords)：
基金项目(Foundation): 国家科技支撑计划(2011BAI11B09)
作者(Author): 卢永昕
参考文献(References)：
- [1]McMurray JJ,Adamopoulos S,Anker SD,et al.ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure2012:The task force for the diagnosis and treatment of acute and chronic heart failure2012of the European Society of Cardiology.Developed in collaboration with the Heart Failure Association(HFA)of the ESC[J].Eur J Heart,2012,33(14):1787-1847.
- [2]Januzzi JL Jr.The role of natriuretic peptide testing in guiding chronic heart failure management:review of available data and recommendation for use[J].Arc cardiovas Dis,2012,105(1):40-50.
- [3]Chitnis AS,Aparasu RR,Chen H,et al.Effect of certain angiotensin-converting enzyme inhibitors on mortality in heart failure:a multiple-propensity analysis[J].Res Social Adm Pharm,2012,8(2):145-156.
- [4]McAlister FA,Wiebe N,Ezekowitz JA,et al.Meta-analysis:β-blocker dose,heart rate reduction,and death in patients with heart failure[J].Ann Intern Med,2009,150(11):784-794.
- [5]Castagno D,Skali H,Takeuchi M,et al.Association of heartrate and outcomes in a broad spectrum of patients with chronic heart failure:results from the CHARM[J].J Am Coll Cardiol.,2012,59(20):1785-1795.
- [6]Bohm M,Borer J,Ford I,et al.Heart rate at baseline influences the effect of ivabradine on cardiovascular outcomes in chronic heart failure:analysis from the SHIFT study[J].Clin Res Cardio,2013,102(1):11-22.
- [7]Roy D,Talajic M,Nattel S,et al.Rhythm control versus rate control for atrial fibrillation and heart failure[J].N Eng J Med,2008,358(25):2667-2677.
- [8]Wann LS,Curtis AB,January CT,et al.2011ACCF/AHA/HRS Focus update on the management of patients with atrial fibrillation:a report of the American College of CardiologyFoundation/American Heart Association Task Force on practice guidelines[J].Circulation,2011,123(1):104-123.
- [9]Whitbeck MG,Charnigo RJ,Khairy P,et al.Increased mortality among patients taking digoxin-analysis from the AFFIRM study[J].Eur Heart J,2012.
- [10]Epstein AE,DiMarco JP,Ellenbogen KA,et al.2012ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS2008guidelines for device-basedtherapy of cardiac rhythm abnormalities:a report of the American College of Cardiology Foundation/AmericanHeart Association Task Force on Practice Guidelines and the Heart Rhythm Society[J].J Am Coll Cardiol,2013,61(3):e6-75.